InnovAge
INNV
#5846
Rank
$1.23 B
Marketcap
$9.08
Share price
0.67%
Change (1 day)
56.55%
Change (1 year)

Earnings for InnovAge (INNV)

Earnings in 2026 (TTM): $0.26 Million USD

According to InnovAge's latest financial reports the company's current earnings are $0.98 Billion USD. In 2025 the company made an earning of $5.1 Million USD, an increase over its 2024 earnings that were of -$26.12 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for InnovAge from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) $0.26 M-94.79%
2025 $5.1 M-119.56%
2024 -$26.12 Million-24.58%
2023 -$34.63 Million-31.82%
2022 -$50.8 Million-681.94%
2021 $8.72 M-388.91%
2020 -$3.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Merck
MRK
$7.69 B 2,890,877.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Cocrystal Pharma
COCP
-$10.11 Million-3,900.75%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-$10.29 Million-3,967.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
$0.51 B 192,585.71%๐Ÿ‡ฎ๐Ÿ‡ช Ireland